319 related articles for article (PubMed ID: 34441012)
1. Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours.
Radulescu LM; Radulescu D; Ciuleanu TE; Crisan D; Buzdugan E; Romitan DM; Buzoianu AD
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441012
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e45-e54. PubMed ID: 27755242
[TBL] [Abstract][Full Text] [Related]
3. Advanced imaging modalities to detect cardiotoxicity.
Awadalla M; Hassan MZO; Alvi RM; Neilan TG
Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
[TBL] [Abstract][Full Text] [Related]
4. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
Akhter N; Murtagh G; Yancy C
Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
[TBL] [Abstract][Full Text] [Related]
5. Assessment and Management of Cardiotoxicity in Hematologic Malignancies.
Bojan A; Torok-Vistai T; Parvu A
Dis Markers; 2021; 2021():6616265. PubMed ID: 33613788
[TBL] [Abstract][Full Text] [Related]
6. Subclinical Cardiotoxicity: The Emerging Role of Myocardial Work and Other Imaging Techniques.
Di Lisi D; Manno G; Novo G
Curr Probl Cardiol; 2021 Jun; 46(6):100818. PubMed ID: 33756178
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: role of echocardiography.
Zito C; Longobardo L; Cadeddu C; Monte I; Novo G; Dell'Oglio S; Pepe A; Madonna R; Tocchetti CG; Mele D
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e35-e44. PubMed ID: 27755241
[TBL] [Abstract][Full Text] [Related]
8. Current views on anthracycline cardiotoxicity.
Mele D; Nardozza M; Spallarossa P; Frassoldati A; Tocchetti CG; Cadeddu C; Madonna R; Malagù M; Ferrari R; Mercuro G
Heart Fail Rev; 2016 Sep; 21(5):621-34. PubMed ID: 27230651
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for monitoring chemotherapy-induced cardiotoxicity.
Cao L; Zhu W; Wagar EA; Meng QH
Crit Rev Clin Lab Sci; 2017 Mar; 54(2):87-101. PubMed ID: 28013560
[TBL] [Abstract][Full Text] [Related]
10. Update on cardiotoxicity of anti-cancer treatments.
Rosa GM; Gigli L; Tagliasacchi MI; Di Iorio C; Carbone F; Nencioni A; Montecucco F; Brunelli C
Eur J Clin Invest; 2016 Mar; 46(3):264-84. PubMed ID: 26728634
[TBL] [Abstract][Full Text] [Related]
11. The role of cardiac biomarkers in cardio-oncology.
Riddell E; Lenihan D
Curr Probl Cancer; 2018 Jul; 42(4):375-385. PubMed ID: 30126650
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: role of echocardiography.
Zito C; Longobardo L; Cadeddu C; Monte I; Novo G; Dell'Oglio S; Pepe A; Madonna R; Tocchetti CG; Mele D
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S35-44. PubMed ID: 27183524
[TBL] [Abstract][Full Text] [Related]
13. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity.
Hernandez-Suarez DF; López-Candales A
Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced myocardial dysfunction - recommendations for assessment in clinical and pre-clinical studies.
Ebrahimi A; Raichlen JS; Pointon A; Gottfridsson C; Munley J; Hockings P; Cartwright J; Buss N; Wikström J; Gan LM; Whittaker A; Khalil A; George RT; Garkaviy P; Brott D
Expert Opin Drug Saf; 2020 Mar; 19(3):281-294. PubMed ID: 32064957
[No Abstract] [Full Text] [Related]
15. Cardiotoxicity due to Chemotherapy: the Role of Biomarkers.
Stevens PL; Lenihan DJ
Curr Cardiol Rep; 2015 Jul; 17(7):603. PubMed ID: 26026994
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S45-54. PubMed ID: 27183525
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity of cancer chemotherapy in clinical practice.
Jain D; Aronow W
Hosp Pract (1995); 2019 Feb; 47(1):6-15. PubMed ID: 30270693
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers.
Nhola LF; Abdelmoneim SS; Villarraga HR; Kohli M; Grothey A; Bordun KA; Cheung M; Best R; Cheung D; Huang R; Barros-Gomes S; Pitz M; Singal PK; Jassal DS; Mulvagh SL
J Am Soc Echocardiogr; 2019 Feb; 32(2):267-276. PubMed ID: 30459123
[TBL] [Abstract][Full Text] [Related]
19. The Role of Biomarkers in Cardio-Oncology.
Ananthan K; Lyon AR
J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
[TBL] [Abstract][Full Text] [Related]
20. Advanced Imaging Modalities to Monitor for Cardiotoxicity.
Seraphim A; Westwood M; Bhuva AN; Crake T; Moon JC; Menezes LJ; Lloyd G; Ghosh AK; Slater S; Oakervee H; Manisty CH
Curr Treat Options Oncol; 2019 Aug; 20(9):73. PubMed ID: 31396720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
